Aurora Kinase Modulators for Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments lack effective solutions for modulating Aurora kinase, which is overexpressed in various cancers, leading to unregulated cell proliferation and tumorigenesis.
Innovation Solution
Development of new compounds defined by Formulas I, II, and III, which exhibit Aurora kinase modulatory activity, specifically inhibiting the enzymes to arrest cell cycling and induce apoptosis, thereby treating cancer and related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current cancer treatments are used, then existing therapy options are available, but they lack effective modulation of Aurora kinase leading to unregulated cell proliferation
Solution Approach 1:
The patent applies parameter changes by modifying chemical structures (Formulas I, II, and III) to create compounds with optimized Aurora kinase binding affinity and selectivity. By systematically varying molecular parameters such as substituent groups, ring structures, and stereochemistry, the invention achieves compounds that effectively modulate Aurora kinase activity while maintaining desired pharmacological properties.
2Reliability
If Aurora kinase is inhibited to arrest cell cycling, then cancer treatment efficacy is improved, but the complexity of compound design and synthesis increases
Solution Approach 1:
The patent applies segmentation by dividing the Aurora kinase inhibitor into distinct molecular segments or pharmacophores. The compounds consist of identifiable functional groups and structural modules that can be independently optimized and combined, facilitating systematic design and synthesis while achieving the desired biological activity.
3Reliability
If new Aurora kinase modulators are developed, then effective cancer treatment is achieved, but the time and resources required for development increase
Solution Approach 1:
The patent applies preliminary action by conducting extensive in silico modeling, in vitro screening, and structure-activity relationship studies before clinical development. The compounds have been pre-tested and validated for Aurora kinase inhibition, cell proliferation arrest, and apoptosis induction, reducing the time required for later development stages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively inhibit Aurora kinases, arresting cell cycling and promoting apoptosis, offering a promising approach for cancer treatment by targeting the Aurora kinase pathway.
Implementation Method 1
The compounds effectively inhibit Aurora kinases, arresting cell cycling and promoting apoptosis
Data Source
AI summary
The present invention relates to chemical compounds having a general formula I {INSERT STRUCTURE HERE} wherein A1-8, D,, L1, L2, R1, R6-8 and n are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinases. For example, the compounds are capable of modulating Aurora kinase thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of Aurora kinase.